191 related articles for article (PubMed ID: 30642799)
21. Changing Strategy Between Bridge to Transplant and Destination LVAD Therapy After the First 3 Months: Analysis of the STS-INTERMACS Database.
Rali AS; Inampudi C; Zalawadiya S; Shah A; Teuteberg JJ; Stewart GC; Cantor RS; Deng L; Jacobs JP; Kirklin JK; Stevenson LW
J Card Fail; 2024 Apr; 30(4):552-561. PubMed ID: 37898382
[TBL] [Abstract][Full Text] [Related]
22. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS).
VanderPluym CJ; Cedars A; Eghtesady P; Maxwell BG; Gelow JM; Burchill LJ; Maltais S; Koehl DA; Cantor RS; Blume ED
J Heart Lung Transplant; 2018 Jan; 37(1):89-99. PubMed ID: 28365175
[TBL] [Abstract][Full Text] [Related]
23. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW
Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928
[TBL] [Abstract][Full Text] [Related]
25. Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry.
Ambardekar AV; Kittleson MM; Palardy M; Mountis MM; Forde-McLean RC; DeVore AD; Pamboukian SV; Thibodeau JT; Teuteberg JJ; Cadaret L; Xie R; Taddei-Peters W; Naftel DC; Kirklin JK; Stevenson LW; Stewart GC
J Heart Lung Transplant; 2019 Apr; 38(4):408-417. PubMed ID: 30948210
[TBL] [Abstract][Full Text] [Related]
26. Global Outcome in Patients With Left Ventricular Assist Devices.
Fendler TJ; Nassif ME; Kennedy KF; Joseph SM; Silvestry SC; Ewald GA; LaRue SJ; Vader JM; Spertus JA; Arnold SV
Am J Cardiol; 2017 Apr; 119(7):1069-1073. PubMed ID: 28160976
[TBL] [Abstract][Full Text] [Related]
27. INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) Profiling Identifies Ambulatory Patients at High Risk on Medical Therapy After Hospitalizations for Heart Failure.
Stewart GC; Kittleson MM; Patel PC; Cowger JA; Patel CB; Mountis MM; Johnson FL; Guglin ME; Rame JE; Teuteberg JJ; Stevenson LW
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27834198
[TBL] [Abstract][Full Text] [Related]
28. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
[TBL] [Abstract][Full Text] [Related]
29. Frequency of Poor Outcome (Death or Poor Quality of Life) After Left Ventricular Assist Device for Destination Therapy: Results From the INTERMACS Registry.
Arnold SV; Jones PG; Allen LA; Cohen DJ; Fendler TJ; Holtz JE; Aggarwal S; Spertus JA
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27507111
[TBL] [Abstract][Full Text] [Related]
30. INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes.
Acharya D; Loyaga-Rendon R; Morgan CJ; Sands KA; Pamboukian SV; Rajapreyar I; Holman WL; Kirklin JK; Tallaj JA
JACC Heart Fail; 2017 Oct; 5(10):703-711. PubMed ID: 28958345
[TBL] [Abstract][Full Text] [Related]
31. Predictors of death and transplant in patients with a mechanical circulatory support device: a multi-institutional study.
Holman WL; Kormos RL; Naftel DC; Miller MA; Pagani FD; Blume E; Cleeton T; Koenig SC; Edwards L; Kirklin JK
J Heart Lung Transplant; 2009 Jan; 28(1):44-50. PubMed ID: 19134530
[TBL] [Abstract][Full Text] [Related]
32. Association of pre-operative interleukin-6 levels with Interagency Registry for Mechanically Assisted Circulatory Support profiles and intensive care unit stay in left ventricular assist device patients.
Caruso R; Verde A; Cabiati M; Milazzo F; Boroni C; Del Ry S; Parolini M; Vittori C; Paino R; Martinelli L; Giannessi D; Frigerio M; Parodi O
J Heart Lung Transplant; 2012 Jun; 31(6):625-33. PubMed ID: 22386451
[TBL] [Abstract][Full Text] [Related]
33. Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation as Destination Therapy at Transplant Versus Nontransplant Centers.
Brinkley DM; DeNofrio D; Ruthazer R; Vest AR; Kapur NK; Couper GS; Kiernan MS
Circ Heart Fail; 2018 Mar; 11(3):e004384. PubMed ID: 29540471
[TBL] [Abstract][Full Text] [Related]
34. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
Starling RC; Estep JD; Horstmanshof DA; Milano CA; Stehlik J; Shah KB; Bruckner BA; Lee S; Long JW; Selzman CH; Kasirajan V; Haas DC; Boyle AJ; Chuang J; Farrar DJ; Rogers JG;
JACC Heart Fail; 2017 Jul; 5(7):518-527. PubMed ID: 28396040
[TBL] [Abstract][Full Text] [Related]
35. Third Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report: Preimplant Characteristics and Outcomes.
Morales DLS; Rossano JW; VanderPluym C; Lorts A; Cantor R; St Louis JD; Koeh D; Sutcliffe DL; Adachi I; Kirklin JK; Rosenthal DN; Blume ED;
Ann Thorac Surg; 2019 Apr; 107(4):993-1004. PubMed ID: 30817920
[TBL] [Abstract][Full Text] [Related]
36. Right heart failure and "failure to thrive" after left ventricular assist device: clinical predictors and outcomes.
Baumwol J; Macdonald PS; Keogh AM; Kotlyar E; Spratt P; Jansz P; Hayward CS
J Heart Lung Transplant; 2011 Aug; 30(8):888-95. PubMed ID: 21530314
[TBL] [Abstract][Full Text] [Related]
37. Assessment of pre-operative psychosocial function among people receiving left ventricular assist devices: A national survey of US LVAD programs.
Clancy MJ; Jessop AB; Eisen H
Heart Lung; 2019; 48(4):302-307. PubMed ID: 30905390
[TBL] [Abstract][Full Text] [Related]
38. End of Life with Left Ventricular Assist Device in Both Bridge to Transplant and Destination Therapy.
Nakagawa S; Garan AR; Takayama H; Takeda K; Topkara VK; Yuzefpolskaya M; Lin SX; Colombo PC; Naka Y; Blinderman CD
J Palliat Med; 2018 Sep; 21(9):1284-1289. PubMed ID: 29874117
[TBL] [Abstract][Full Text] [Related]
39. Impact of adverse events on health-related quality of life after left ventricular assist device implantation: An STS INTERMACS analysis.
Kilic A; Kwon JH; Grady KL; Singletary BA; Kilic A; Everitt M; Cleveland J; Cantor RS; Blackmon S; Breathett K; McKellar S; Keebler M; Kirklin JK; Stehlik J
J Heart Lung Transplant; 2023 Sep; 42(9):1214-1222. PubMed ID: 37040860
[TBL] [Abstract][Full Text] [Related]
40. Quantifying the impact from stroke during support with continuous flow ventricular assist devices: An STS INTERMACS analysis.
Kirklin JK; Naftel DC; Myers SL; Pagani FD; Colombo PC
J Heart Lung Transplant; 2020 Aug; 39(8):782-794. PubMed ID: 32376278
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
